US FDA ups the ante against antimicrobial resistance
The US FDA announced a number of measures it considers as a viable means of combatting AMR, including the idea of hospitals paying a ‘subscription’ to access new medicines.
Top Headlines
Global Industry News
-
Collaboration to use companion diagnostics for cholangiocarcinoma treatment
from Outsourcing-Pharma.com
-
The third generation of large molecule drugs? Controlled-release biologics, says DelSiTech
from BioPharma-Reporter.com
-
Thermo Fisher expands bioprocessing with BD acquisition
from BioPharma-Reporter.com
-
Sekisui XenoTech expands test systems with rodent, monkey hepatocytes
from Outsourcing-Pharma.com
